Advanced search
Publication Cover
Modern Rheumatology Case Reports Volume 4, 2020 - Issue 1
Journal homepage
105
Views
3
CrossRef citations to date
0
Altmetric
Case Reports

Bucillamine-induced gigantomastia with galactorrhea and hyperprolactinaemia

Tatsuo MoriDepartment of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0001-6338-3211
ORCID Icon,
Naoto YokogawaDepartment of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan;
,
Ryohei HiguchiDepartment of Plastic and Reconstructive Surgery, Tokyo Metropolitan Matsuzawa Hospital, Tokyo, Japan;
,
Motoyoshi TsujinoDepartment of Endocrinology and Metabolism, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan
,
Kota ShimadaDepartment of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan;
&
Shoji SugiiDepartment of Rheumatic Diseases, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan;
Pages 122-125 | Received 26 Jul 2019, Accepted 24 Sep 2019, Published online: 14 Oct 2019

References

  • Sakai Y, Wakamatsu S, Ono K, et al. Gigantomastia induced by bucillamine. Ann Plast Surg. 2002;49(2):193–195.
  • Scott EH. Hypertrophy of the breast, possibly related to medication: a case report. S Afr Med J. 1970;44(15):449–450.
  • Desai SN. Sudden gigantism of breasts: drug induced? Br J Plast Surg. 1973;26(4):371–372.
  • Craig HR. Penicillamine induced mammary hyperplasia: report of a case and review of the literature. J Rheumatol. 1988;15(8):1294–1297.
  • Rooney PJ, Cleland J. Successful treatment of D-penicillamine-induced breast gigantism with danazol. Br Med J (Clin Res Ed). 1981;282(6276):1627–1628.
  • Passas C, Weinstein A. Breast gigantism with penicillamine therapy. Arthritis Rheum. 1978;21(1):167–168.
  • Thew DC, Stewart IM. D penicillamine and breast enlargement. Ann Rheum Dis. 1980;39(2):200.
  • Taylor PJ, Cumming DC, Corenblum B. Successful treatment of D-penicillamine-induced breast gigantism with danazol. Br Med J (Clin Res Ed). 1981;282(6261):362–363.
  • Reid DM, Martynoga AG, Nuki G. Reversible gynaecomastia associated with D-penicillamine in a man with rheumatoid arthritis. Br Med J (Clin Res Ed). 1982;285(6348):1083–1084.
  • Finer N, Emery P, Hicks BH. Mammary gigantism and D-penicillamine. Clin Endocrinol. 1984;21(3):219–222.
  • Kahl LE, Medsger TA, Klein I. Massive breast enlargement in a patient receiving D-penicillamine for systemic sclerosis. J Rheumatol. 1985;12(5):990–991.
  • Rose BI, LeMaire WJ, Jeffers LJ. Macromastia in a woman treated with penicillamine and oral contraceptives. A case report. J Reprod Med. 1990;35(1):43–45.
  • de Pablo Lozano JL. Gigantismo mamario inducido por D-penicilamina. Descripcion de un caso y revision de la literatura. Rev Senología y Patol Mam 1993;6(2):91–96.
  • Desautels JE. Breast gigantism due to D-penicillamine. Can Assoc Radiol J. 1994;45(2):143–144.
  • Upponi S, Jadav A, Bobrow L, et al. Re: breast hypertrophy related to D-penicillamine? The Breast. 2001;10(4):349–350.
  • Tchebiner JZ. Breast enlargement induced by D-penicillamine. Ann Pharmacother. 2002;36(3):444–445.
  • Touraine P, Youssef N, Alyanakian MA, et al. Breast inflammatory gigantomastia in a context of immune-mediated diseases. J Clin Endocrinol Metab. 2005;90(9):5287–5294.
  • Lee JE, Shin HJ, Hwang SE, et al. A case of breast gigantism in a patient with Wilson’s disease treated by penicillamine. J Breast Cancer. 2006;9(1):69.
  • Tan SS, Abdul Latif S, Poh WY. Concurrent massive breast enlargement, myasthenia gravis and dermopathy as manifestations of Penicillamine toxicity in a Wilson’s disease patient. Med J Malaysia. 2012;67:323–325.
  • Courtillot C, Plu-Bureau G, Sigal-Zafrani B, et al. Benign breast diseases. J Mammary Gland Biol Neoplasia. 2005;10(4):325–335.
  • Bandeira R, Ribeiro T, Neto G. Fibroadenoma of the axilla in a patient with macroprolactinoma. J Med Cases. 2011;2:279–283.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.